Close Menu

NEW YORK – Lucira Health, a startup formerly known as Diassess, announced today it has closed a $15 million Series B equity financing round.

The Emeryville, California-based developer of instrument-free, molecular diagnostics for infectious disease testing intends to use the funds to finance regulatory clearances and early commercialization.

The funding was led by Seraph Group with participation from Eclipse Ventures, DCVC (Data Collective), Y Combinator, Sunstone Management, and ShangBay Capital, the firm said in a statement.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.